Refractory, metastatic hormone-refractory Prostate cancer
Also known as: Metastatic Prostate Carcinoma / Prostate Cancer Metastatic / Metastatic Prostate Cancer / Metastatic Hormone Refractory Prostate Cancer / Carcinoma of the prostate metastatic / Prostatic cancer metastatic
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB06772 | Cabazitaxel | An antineoplastic agent used for the treatment of hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing treatment regimen. |
| DB04839 | Cyproterone acetate | A steroid used in combination with ethinyl estradiol to treat women with severe acne and symptoms of androgenization. Also used alone at much higher doses for palliative treatment of patients with prostate cancer |
| DB01248 | Docetaxel | A taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer. |
| DB01196 | Estramustine | An antineoplastic agent used for the management of metastatic and/or progressive prostate cancer in palliative setting. |
| DB00665 | Nilutamide | An antineoplastic hormone used to treat prostate cancer. |